Login / Signup

Open trial of recombinant Der f 2 pullulan-conjugated immunotherapy in cats.

Franco MartiniAna RostaherClaude FavrotNina Maria Fischer
Published in: Veterinary dermatology (2023)
Allermmune HDM may be safe in cats and has the potential to alleviate signs of atopic skin syndrome. Allergen-specific IgE levels may represent an efficacy marker. Controlled studies of longer duration and larger sample size are worth pursuing.
Keyphrases
  • minimally invasive
  • study protocol
  • phase iii
  • clinical trial
  • photodynamic therapy
  • phase ii
  • soft tissue
  • case control
  • atopic dermatitis
  • cell free